Polycystic ovary syndrome is the most common endocrinopathy among reproductive-aged women in the United States, affecting approximately 7% of female patients. Although the pathophysiology of the syndrome is complex and there is no single defect from which it is known to result, it is hypothesized that insulin resistance is a key factor. Metabolic syndrome is twice as common in patients with pol...

Background: Polycystic ovary syndrome is a common endocrine disorder with 3-7% prevalence in the general population and 10% in women of childbearing. This rate has increased in infertile women. The main composition of this syndrome includes anovulation or olygoovulation, clinical and laboratory signs of increased androgens and observation polycystic ovaries on ultrasound in evaluation. In this ...

Background: To estimate the prevalence of polycystic ovarian syndrome (PCOS) in Chinese women comprehensively and to provide references prevent PCOS.

The Key Role of Inflammation and Oxidative Stress in Polycystic Ovary Syndrome Testicular Torsion: A Review Their Induction Rat Model

Objective: To compare the efficacy of clomiphene citrate and with metformin in anovulatory infertility PCOS (polycystic ovarian syndrome (PCOS). Study Design: Randomized controlled trial. Place Duration Study: This research took place Department Gynecology Obstetrics at combined military hospital Bahawalpur. The study was carried out over a six-month period, starting on 1st November 2022 conclu...

Women with polycystic ovary syndrome who present with hyperandrogenemia, hyperinsulinemia, and insulin resistance appear to be at high risk of cardiovascular disease. Elevated levels of endothelin-1, a marker of vasculopathy, have been reported in insulin-resistant subjects with endothelial dysfunction. Male gender also seems to be an aggravating factor for cardiovascular disease. In this study...